Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects
about
sameAs
Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York CityClinical management of transsexual subjectsChallenges in Transgender Healthcare: The Pathology PerspectiveMad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsTransmasculine people's vocal situations: a critical review of gender-related discourses and empirical data.Transgender identity and health care: implications for psychosocial and physical evaluation.The Role of Androgens in Normal and Malignant Breast Tissue.Gynaecological aspects of the treatment and follow-up of transsexual men and women.Medical management of adult transsexual persons.Report of the American Psychiatric Association Task Force on Treatment of Gender Identity Disorder.A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria.Gender identity and sport: is the playing field level?The role of androgens in hormone replacement therapy.Adverse orthopedic effect of exogenous estrogens on men undergoing cross-gender hormonal therapy.Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axisCancer's Margins: Trans* and Gender Nonconforming People's Access to Knowledge, Experiences of Cancer Health, and Decision-MakingCurrent management of male-to-female gender identity disorder in the UK.Transgender populations and HIV: unique risks, challenges and opportunities.Suicide risk factors among trans feminine individuals in Lebanon.SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders.Hormonal management of the female-to-male transgender patient.Cross-sex hormone therapy for gender dysphoria.Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen.Pharmacotherapy Considerations in the Management of Transgender Patients: A Brief Review.Oestrogen and anti-androgen therapy for transgender women.PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude.Drug Therapy for Gender Transitions and Health Screenings in Transgender Older Adults.Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.Perceptual analysis of the male-to-female transgender voice after glottoplasty-the telephone test.Body Image in Young Gender Dysphoric Adults: A European Multi-Center Study.The Response of the Menstrual Cycle to Initiation of Hormonal Therapy in Transgender Men.Structural Inequities and Social Networks Impact Hormone Use and Misuse Among Transgender Women in Los Angeles County.Effects of Adult Female Rat Androgenization on Brain Morphology and Metabolomic Profile.Surgical and pharmacological reassignment: influence on transsexual cardiovascular risk profile.Treating a transgender patient: overview of the guidelines.Male-to-female transsexual surgery: experience at the UFRJ University Hospital.Cross-sex hormonal replacement: is this really effective? an experimental clue.Status of sex reassignment surgery for gender identity disorder in Japan.An evaluation of service utilization among male to female transgender youth: qualitative study of a clinic-based sample.Testosterone stimulates growth and secretory activity of the female prostate in the adult gerbil (Meriones unguiculatus).
P2860
Q24652232-6C3088E2-678E-4586-9757-E304686BA31EQ26823448-C58BB353-9A9F-4F81-826F-7E1C3D8157C8Q30249673-7F86E5FF-5302-491B-951E-7F87CE922F80Q30364736-EC366CE3-A94F-4C62-BE83-803C68086018Q30847145-473B58D3-CB40-4438-83CE-1B3B48AB3562Q34026518-3F7224FA-3617-4D33-9589-001A6E324726Q34096288-881199B5-EE2C-4101-9911-4883ECA4690BQ34132096-082B5AAD-B728-432D-8DE1-A97975EE086FQ34258902-80B20D86-0247-4CFE-8746-F6EA92347158Q34284364-0F4F634A-9140-45FE-9EDD-780C1F5CE635Q34474654-0C9B9A5B-913F-4C5D-972C-BD99A9201F6DQ35331118-3F9EFC70-8A87-4D0B-9458-442B12A7B202Q36249910-336413C9-5B4E-4746-BCC0-6FC50EE08835Q36328035-862BD51B-270A-4CEA-9180-047D6CDB7713Q36528250-3B06F6A8-3FD9-43EF-A26E-6C9014B3184DQ36629866-C19BE772-A052-4EE0-A50D-E8820246403AQ36960860-9B2A6DC6-388D-4873-AA43-B35711DADB09Q37136266-85AE7AAC-E2B0-4026-83F5-BB789E6DBE14Q37234497-21028D3F-9FFA-4323-A367-1B23347FB941Q37672115-51CAC04D-9A0B-40BE-85FC-4FA4797EEE93Q37871048-8E067370-5C5F-4B01-B409-B5F02FADB851Q38268810-0FDDF213-F711-41C1-947D-0DD90C86B97BQ38360342-B05D1D94-AFA0-43C5-90EA-74FC86779E42Q38673882-4D58F18F-8D47-405F-8852-0F9E204303EFQ38787403-DC713ECD-CE4C-48D6-B4E9-6D635431D793Q38963524-C8C8559C-2678-47F9-AFB1-23D471ECF604Q39044390-6ED663DC-EBEE-42B1-804B-62234FBFB3CEQ39435553-988481BF-1027-43AB-9A33-69B3E2B8FF0DQ39661928-B06A462B-A69B-4E19-8852-CB837AE487E7Q41121420-FE003A18-B69E-48FB-A339-6B4CAC2B79CEQ47152921-989C66D5-340A-4EE3-9615-F231CD2B7FFBQ47563483-FB1A6892-D46F-4D72-AB15-8F0EF47817B2Q47589145-B8124FA0-3A9C-4E2E-96C1-5BEF624CDF79Q47707632-C84ACAA6-CB9B-47D4-8D7C-43A5281F8F54Q50613629-2272DF6D-CF26-45C0-B7CB-7637530DE537Q51054576-52B0573D-2E7E-4FE0-8438-22B90B673563Q51270792-E6D25255-3F88-4295-8D25-6F7DC2319212Q51356824-85392AC7-C918-4272-A985-EF169FCECC00Q51772264-02F5179D-38D6-46B3-A065-14CF551BDF88Q51804675-733948C0-21BA-4D30-856E-BE0773CC8577
P2860
Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Endocrine treatment of transse ...... outcomes, and adverse effects
@ast
Endocrine treatment of transse ...... outcomes, and adverse effects
@en
Endocrine treatment of transse ...... outcomes, and adverse effects
@nl
type
label
Endocrine treatment of transse ...... outcomes, and adverse effects
@ast
Endocrine treatment of transse ...... outcomes, and adverse effects
@en
Endocrine treatment of transse ...... outcomes, and adverse effects
@nl
prefLabel
Endocrine treatment of transse ...... outcomes, and adverse effects
@ast
Endocrine treatment of transse ...... outcomes, and adverse effects
@en
Endocrine treatment of transse ...... outcomes, and adverse effects
@nl
P2093
P356
P1476
Endocrine treatment of transse ...... outcomes, and adverse effects
@en
P2093
Adrian Dobs
Amy Wisniewski
P304
P356
10.1210/JC.2002-021967
P407
P577
2003-08-01T00:00:00Z